Nexium Lawsuit Filed By Bernstein Liebhard LLP On Behalf of Illinois Man Who Developed Chronic Kidney Disease Allegedly Related to Use of the Proton Pump Inhibitor

NEW YORK, Sept. 19, 2016 /PRNewswire/ -- The nationwide law firm of Bernstein Liebhard LLP announces that they have filed a Nexium lawsuit (http://www.nexiumlawsuit.com/) on behalf of an Illinois man who developed chronic kidney disease allegedly related to the long-term use of the proton pump inhibitor. The complaint, which was filed on August 26th in the U.S. District Court, Eastern District of New York, alleges that AstraZeneca Pharmaceuticals LP and AstraZeneca LP were aware of reports linking Nexium to chronic kidney disease and other renal complications, yet continued to represent that the drug did not pose any risks to the kidneys. (Case No. No. 16-04801)

"Our Firm has been contacted by hundreds of people who allegedly suffered kidney disease, renal failure, and other kidney complications due to their use of Nexium and other proton pump inhibitors. We are continuing to investigate potential cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP. The Firm is now offering free legal reviews to individuals who were diagnosed with chronic kidney disease, kidney failure, acute kidney injury, or acute interstitial nephritis following extended use of prescription or over-the-counter proton pump inhibitors.

Proton Pump Inhibitors and the Kidneys

Proton pump inhibitors like Nexium are indicated for the short-term treatment of ailments related to the excess production of stomach acid, such as gastroesophageal reflux disease (GERD), dyspepsia, acid peptic disease, peptic or stomach ulcers, and Zollinger-Ellison syndrome. Other prescription medications in this class incude:

• Prilosec (omeprazole)
• PrevAcid (lansoprazole)
• Dexilent, Kapidex (dexlansoprazole)
• Aciphex (rabeprazole)
• Protonix (pantoprazole)
• Vimovo (naproxen and esomeprazole magnesium)
• Zegerid (omeprazole and sodium bicarbonate)

Over-the-counter versions, including Nexium 24HR, Prilosec OTC, and PrevAcid 24HR, are also available.

According to the complaint filed by Bernstein Liebhard LLP, Nexium is AstraZeneca's largest-selling drug, with sales exceeding $5.2 billion in 2008. In 2013, more than 15 million Americans used prescription proton pump inhibitors, at a cost of more than $10 billion. However, it has been estimated that between 25% and 70% of these prescriptions have no appropriate indication.

Several recent studies have suggested that Nexium and other proton pump inhibitors may pose a risk to the kidneys. In April, researchers writing in the Journal of the American Society of Nephrology reported that long-term users of proton pump inhibitors may be 96% more likely to develop kidney failure and 28% more likely to develop chronic kidney disease compared to patients using another class of heartburn drugs called H2-blockers. A study published in JAMA Internal Medicine in January also suggested that proton pump inhibitors might increase the risk of chronic kidney disease by as much as 50%. 

In 2014, the U.S. Food & Drug Administration required all manufacturers of prescription proton pump inhibitors to add new information regarding acute interstitial nephritis to their product labels. This sudden inflammation of the kidney tubules is often the result of an allergic reaction to a medication. Untreated, the disorder can lead to kidney disease and renal failure.

In April 2015, a study published in CMAJ Open linked proton pump inhibitors to a 3-fold increase in the risk for acute interstitial nephritis, as well as a 2.5 times higher risk of acute kidney injury.

Individuals who were diagnosed with serious kidney complications following treatment with Nexium or another proton pump inhibitor may be entitled to compensation for medical bills, lost wages, pain and suffering, and any other injury-related damages they incurred. To learn more about filing a Nexium lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.nexiumlawsuit.com/
https://plus.google.com/115936073311125306742?rel=autho

Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

SOURCE Bernstein Liebhard LLP

Related Links

http://www.bernlieb.com